IPXL Financial Facts
Patent litigation: 2.11MIncome before income taxes: 25.67M
See Full Income Statement
Deferred income taxes: 40.65M
Total current liabilities: 137.88M
See Full Balance Sheet
Impax Laboratories Inc. (IPXL) Earnings
|
Expand Research on IPXL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/1/18 |  |
Q417 | $0.11 | $0.11 | $0.00 | $182.9M | $198.17M | N/A |  | | Details |
| 11/9/17 | |
Q317 | $0.23 | $0.20 | +$0.03 | $206.4M | $208.36M | N/A | | | Details |
| 8/9/17 | |
Q217 | $0.18 | $0.14 | +$0.04 | $202.1M | $195.62M | N/A | | | Details |
| 5/10/17 | |
Q117 | $0.11 | $0.13 | -$0.02 | $184.4M | $191.25M | N/A | | | Details |
| 3/1/17 | |
Q416 | $0.16 | $0.16 | $0.00 | $198.4M | $219.25M | N/A | | | Details |
11/9/16  |
|
Q316 | $0.37 | $0.39 | -$0.02 | $228M | $234.87M | N/A | | | Details |
| 8/9/16 |
|
Q216 | $0.21 | $0.32 | -$0.11 | $173M | $223.67M | N/A | | | Details |
| 5/10/16 |
|
Q116 | $0.43 | $0.39 | +$0.04 | $226M | $247.2M | N/A | | | Details |
